We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Axsome Therapeutics
AXSM
$11.4B
| $1.22M | ﹤0.01% |
29,421
-165
| -0.6% | -$5.12K |
|
2052
Madrigal Pharmaceuticals
MDGL
$11.9B
| $1.22M | ﹤0.01% |
12,393
+451
| +4% | +$38K |
|
|
TSP
2053
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.21M | ﹤0.01% |
99,523
-14,122
| -12% | -$245K |
|
|
MGI
2054
DELISTED
MoneyGram International, Inc. New
MGI
| $1.21M | ﹤0.01% |
114,728
-4,650
| -4% | -$44.7K |
|
2055
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.21M | ﹤0.01% |
43,336
+8
| +0% | +$209 |
|
2056
Comtech Telecommunications
CMTL
$51.5M
| $1.21M | ﹤0.01% |
77,019
-322
| -0.4% | -$6.33K |
|
2057
Haverty Furniture Companies
HVT
$451M
| $1.21M | ﹤0.01% |
43,948
-56,090
| -56% | -$1.63M |
|
2058
Organogenesis Holdings
ORGO
$239M
| $1.2M | ﹤0.01% |
158,051
+39,208
| +33% | +$303K |
|
|
ECHO
2059
EchoStar
ECHO
$25.9B
| $1.2M | ﹤0.01% |
49,429
-3,428
| -6% | -$84.5K |
|
|
IMGN
2060
DELISTED
Immunogen Inc
IMGN
| $1.2M | ﹤0.01% |
252,088
-16,232
| -6% | -$89.9K |
|
2061
Costamare
CMRE
$1.74B
| $1.2M | ﹤0.01% |
70,328
-9,596
| -12% | -$137K |
|
|
KYNB
2062
Kyntra Bio
KYNB
$28.2M
| $1.2M | ﹤0.01% |
3,989
-177
| -4% | -$61.7K |
|
2063
Independent Bank Corp
IBCP
$841M
| $1.2M | ﹤0.01% |
54,491
-6,614
| -11% | -$159K |
|
2064
Central Garden & Pet Co
CENT
$2.75B
| $1.2M | ﹤0.01% |
34,028
-386
| -1% | -$14.3K |
|
2065
Tidewater
TDW
$4.46B
| $1.2M | ﹤0.01% |
54,951
-6,562
| -11% | -$104K |
|
2066
Universal Electronics
UEIC
$71.6M
| $1.19M | ﹤0.01% |
38,169
-1,178
| -3% | -$40.8K |
|
|
ZIMV
2067
DELISTED
ZimVie
ZIMV
| $1.19M | ﹤0.01% |
+52,112
| New | +$1.23M |
|
|
LL
2068
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.18M | ﹤0.01% |
84,259
-177
| -0.2% | -$2.7K |
|
|
EVOP
2069
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.17M | ﹤0.01% |
50,633
-289
| -0.6% | -$6.87K |
|
2070
Conduent
CNDT
$242M
| $1.17M | ﹤0.01% |
226,059
-20,181
| -8% | -$99.3K |
|
|
ENDP
2071
DELISTED
Endo International plc
ENDP
| $1.16M | ﹤0.01% |
503,549
-10,345
| -2% | -$30.3K |
|
2072
MannKind Corp
MNKD
$1.26B
| $1.16M | ﹤0.01% |
315,668
-20,833
| -6% | -$76.1K |
|
2073
Rayonier Advanced Materials
RYAM
$593M
| $1.16M | ﹤0.01% |
176,885
+1,250
| +0.7% | +$7.6K |
|
2074
Marcus Corp
MCS
$921M
| $1.16M | ﹤0.01% |
65,539
-1,219
| -2% | -$21.4K |
|
2075
CVR Energy
CVI
$3.26B
| $1.15M | ﹤0.01% |
45,196
+2,915
| +7% | +$60.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.